Alkaline phosphatase concentrations are known to increase in blood neutrophils of normal pregnant women. The main kinetic parameters of this enzyme were analysed and compared in a group of 30 women with normal pregnancies and a group of II women whose fetuses had trisomy 21 (Down's syndrome = DS). The subjects were studied at an identical stage of gestation. Significant changes occurred in thermal stability and urea resistance in cases of DS pregnancies. We also investigated the inactivation constants for two chemicals: L-p-bromotetramisole, an uncompetitive inhibitor, and sodium thiophosphate, a competitive inhibitor. Ki measured for the two inhibitors were found to be significantly lower in cases of pathological pregnancies. The patterns observed in inhibition constants extend the biochemical characteristics of the atypical isoenzyme expressed in neutrophils of women with DS pregnancies.
SUMMARY. Alkaline phosphatase concentrations are known to increase in blood neutrophils of normal pregnant women. The main kinetic parameters of this enzyme were analysed and compared in a group of 30 women with normal pregnancies and a group of II women whose fetuses had trisomy 21 (Down's syndrome = DS). The subjects were studied at an identical stage of gestation. Significant changes occurred in thermal stability and urea resistance in cases of DS pregnancies. We also investigated the inactivation constants for two chemicals: L-p-bromotetramisole, an uncompetitive inhibitor, and sodium thiophosphate, a competitive inhibitor. Ki measured for the two inhibitors were found to be significantly lower in cases of pathological pregnancies. The patterns observed in inhibition constants extend the biochemical characteristics of the atypical isoenzyme expressed in neutrophils of women with DS pregnancies.
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Alkaline phosphatases (AP; EC.3.1.3.I) are synthesized ubiquitously in nature by prokaryotic and eukaryotic organisms. Despite intensive studies, their physiological role remains obscure probably due to differences in the catalytic action of isoenzymes in a specific tissue. From current investigation three main catalytic functions can be attributed to these enzymes: (a) hydrolysis of low molecular weight phosphomonoesters;' (b) phosphotransferase activityr' and (c) protein phosphatase activity. ' Alkaline phosphotase had been detected in circulating blood cells, mainly in polymorphonuclear leukocytes or neutrophils. Levels of activity vary considerably in certain neutrophil disorders and in pregnancy," A major genetic defect exhibiting a significant increase in neutrophil AP is trisomy 21 (Down's syndrome, DS) the most common human autosomal aneuploidy.
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Neutrophil AP (NAP) has been shown to have an altered reactivity in trisomy 21 pregnancies, characterized by: (I) a lower rate of enzyme activity; (2) a greater stability to heat and urea denaturation; and (3) marked changes in immunoreactivity.? These findings led us to investigate the kinetic parameters of abnormal NAP in such a group of women. This article discusses further the kinetic analysis of the enzyme and the effect of L-p-bromotetramisole (LpBT), a potent, uncompetitive inhibitor of liver/bone/kidney AP and of sodium thiophosphate, a competitive inhibitor of some AP isoenzymes."
PATIENTS AND METHODS

Subjects
Eleven blood samples from unrelated women bearing a fetus with trisomy were karyotyped after amniocentesis. Thirty specimens from a control group with normal pregnancy were also examined. The permission of all patients was obtained before blood was collected and each woman gave her informed consent. The mean age of the patients carrying a trisomy 21 fetus was 36 ± 6 years and in the control group the mean age was 31 ± 5 years.
The women in the trisomy 21 group belonged to the class of 'at risk' pregnancies. A transabdominal amniocentesis was done for diagnostic purpose during weeks 19 and 20 of gestation. Indications for amniocentesis were high maternal age, or previous delivery of a child with a chromosomal abnormality. Karyotypes were determined from fetal cells grown from the amniotic sample. In all cases reported, karyotyping of the fetus cells revealed a free homogeneous trisomy.
Blood specimens were collected on controls at the same stage of gestation. Women undergoing normal pregnancy were selected during a systematic check-up performed at the outpatients clinic of the Department of Gynaecology and Obstetrics. The results of neutrophil alkaline phosphatase studies were only included in our control data after the delivery of liveborn children with no observed clinical malformations.
Cells preparation and NAP extraction
Methodology used for neutrophil isolation and AP recovery was as described.' NAP assays and kinetic measurements Kinetic measurements were done in triplicate at 37°C and pH 9'5, in diethanolamine buffer 0·2 mol/L containing 45 mmol/L MgCI 2 , ionic strength maintained constant (0·15) with NaCl, using pNPP 10 mrnol/L as substrate.
Measurements were made on a Perkin Elmer UV-Visible spectrophotometer Lamda 15, by monitoring at 400 nm the release of p-nitrophenate (e apparent = 11800mol-1.L.cm-1 at pH = 9·5) for at least 5 min. The initial velocities were determined using the PECSS software installed on the spectrophotometer.
Inhibition studies used the inhibitor LpBT at concentrations varying from 0·02 mmol/L to 0·2mmol/L without preliminary incubation. Sodium thiophosphate and enzyme were incubated together for 5 min before adding the substrate sodium paranitrophenylphosphate (pNPP).
Specific activity (Vmax) is expressed in katals per milligram protein (precisely as nkat/mg), which is defined as that amount of enzyme that will convert 1mol of substrate per second under the conditions specified for the assay, related to 1mg of protein.
Data analysis
All data collected were analysed using the computer program CINENZY based on the Michaelis-Menten equation, giving the best fit with the experimental data for K m (Michaelis-Menten constant), Vrna" K, (inhibition constant) values and several plots, linear or curved: Lineweaver-Burk, Eadie-Hofstee, Hanes-Woolf and Briggs-Haldane plots.
RESULTS
Inhibitory patterns in normal pregnancy samples
Variations observed in K m and K, values for the two inhibitors are summarized in Table 1 . LpBT can be used as an additional tool to discriminate NAP isoenzymes expressed In normal and trisomy 21 pregnancies. Sodium thiophosphate is a competitive inhibitor formerly used with Escherichia coli APs. Mammalian APs isoenzymes appear never to have been investigated with this compound. Due to its steric properties, thiophosphate would be expected to bind to the active site of NAP. The Hanes-Woolf plots obtained showed a different degree of inhibition of NAPs in affected pregnancies compared to normal controls. The finding of lowered K, values would indicate an increased accessibility of inhibitor to the active site of the enzyme.
LpBT is a stereospecific and non-competitive inhibitor of APs. It represents a particularly potent inhibitor of liver/bone/kidney AP but has little effect on the other isoenzymes. Regarding the mechanism of inhibition, it has been
DISCUSSION
The findings reported in this study indicate that the inhibition by sodium thiophosphate and Distribution of mean values ± SD (standard deviation) is reported for the samples examined at different weeks of gestation.
The analysis of K m shows little vanations during the periods of pregnancy considered. A median value of K m = 124 /lmol/L is found with an SD of 12 (range 112-147 /lmol/L).
The same pattern is found for K, determined in the case of LpBT and sodium thiophosphate. The stage of pregnancy does not significantly alter values of K, and the range was 123-130/lmol/L for LpBT and 201-215 /lmol/L for thiophosphate. LpBT seems to be a more effective inhibitor than sodium thiophosphate (the value of the ratio K, thio/Km is always greater than K, letralK m and the value of the ratio K, Ihio/ K, tetra is in all cases> I).
Conversely, Vmax is characterized by a mean significant increase as a function of the stage of pregnancy between weeks 16 and 23. However, individual variations occur. A similar trend has been reported for total serum AP.
Inhibitory patterns in trisomy 21 pregnancy samples
The results obtained in pathological cases of pregnancy examined are shown in Table I . A comparison is made with normal controls at the same period of gestation (weeks 19-21).
An increase in K m values was observed. For example K; was 1-45 times greater in affected pregnancies compared to the control group at week 19. K m seems to be constant in this period and the range was 156-163 /lmol/L.
Vmax was slightly lower compared to that of normal pregnancies at the same stage. For example NAP activity was 24 times less at week 21 compared to the control group. K, for LpBT and thiophosphate gave diminished figures compared to those of normal pregnancies. The value of the ratio K, thjo/Kj tetra is also > I showing that LpBT was a more effective inhibitor than thiophosphate. The K, tetra and K, thio/Km are both < I which differs significantly from the values for normal pregnancies. For example, K, thio/Km is about two times lower in affected pregnancies compared to the control group at week 20 (range 0·55--0·65 for LpBT and 0·76--Q·90 for thiophosphate). These inhibitors were more effective in affected pregnancies compared to controls.
suggested that a poorly dissociable enzymeinhibitor substrate complex is formed, since the inhibition is dependent on both inhibitor and substrate concentrations before saturation of each is reached. The mechanism has been described as a trapping of the phosphorylated intermediate of the enzyme by the inhibitor. The functional groups of the molecule (probably the tetrahydroimidazo 2-1 thiazole) would participate in the process.
We have noticed that these inhibitors are more efficient in cases of abnormal pregnancies, LpBT displaying the best inhibitory effect. Recent studies conducted by site directed mutagenesis at identical positions in murine tissue non-specific AP and human APPL c DNAs have shown the importance of a domain of the molecule representing the surface loop of 40 amino acids, in determining or influencing non-competitive inhibitor properties." The structure of this loop facilitates the accessibility of the inhibitor to the active site residues and stabilizes the compound during inhibition by specific binding. The same surface loop plays a crucial role in determining enzyme heat stability.
Measurements of inhibition constants of NAP strengthen biochemical criteria aimed at the identification of an abnormal enzyme in cases of pathological pregnancies. Data obtained in this study add further biochemical characteristics to the enzymatic pattern found in blood neutrophil APs in mothers with trisomic 21 fetuses.
